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Abstract 
Rationale: The incidence of gestational diabetes mellitus (GDM) is increasing worldwide. However, whether 
and how GDM exposure induces fetal programming of adult cardiac dysfunctional phenotype, especially the 
underlying epigenetic molecular mechanisms and theranostics remain unclear. To address this problem, we 
developed a late GDM rat model.  
Methods: Pregnant rats were made diabetic on day 12 of gestation by streptozotocin (STZ). Experiments 
were conducted in 6 weeks old offspring.  
Results: There were significant increases in ischemia-induced cardiac infarction and gender-dependent left 
ventricular (LV) dysfunction in male offspring in GDM group as compared to controls. Exposure to GDM 
enhanced ROS level and caused a global DNA methylation in offspring cardiomyocytes. GDM attenuated 
cardiac Sirt 1 protein and p-Akt/Akt levels, but enhanced autophagy-related proteins expression (Atg 5 and 
LC3 II/LC3 I) as compared to controls. Ex-vivo treatment of DNA methylation inhibitor, 5-Aza directly 
inhibited Dnmt3A and enhanced Sirt 1 protein expression in fetal hearts. Furthermore, treatment with 
antioxidant, N-acetyl-cysteine (NAC) in offspring reversed GDM-mediated DNA hypermethylation, Sirt1 
repression and autophagy-related gene protein overexpression in the hearts, and rescued GDM-induced 
deterioration in heart ischemic injury and LV dysfunction.  
Conclusion: Our data indicated that exposure to GDM induced offspring cardiac oxidative stress and DNA 
hypermethylation, resulting in an epigenetic down-regulation of Sirt1 gene and aberrant development of heart 
ischemia-sensitive phenotype, which suggests that Sirt 1-mediated signaling is the potential therapeutic target 
for the heart ischemic disease in offspring. 
Key words: GDM, ROS, Sirt 1, DNA methylation, heart ischemia-sensitive phenotype 
Introduction 
The prevalence of gestational diabetes mellitus 
(GDM) has been increasing all over the world and 
growing evidence suggests that GDM has adverse 
effects not only on mothers but also on their offspring 
[1]. Previous studies have reported that GDM could 
cause cardiac development defects and increase 
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morbidity of congenital heart defects [2]. 
Furthermore, maternal GDM has been shown to act as 
an independent risk factor for development of 
cardiovascular disease in offspring late in life [3]. 
However, the molecular epigenetic mechanisms 
underlying the maternal GDM-induced development 
of heart dysfunctional phenotypes in offspring are not 
fully understood. 
Several molecular epigenetic mechanisms 
including DNA methylation, histone modification, 
and small non-code RNAs may play a key role in 
epigenetic inheritance and aberrant development of 
cardiovascular disease in late life. DNA methylation is 
the major mechanism in modification of gene 
expression patterns, and occurs at cytosine of the 
dinucleotide sequence CpG [4, 5]. Methylation in gene 
promoter regions is generally associated with a 
long-term shutdown of the associated gene. Clinical 
studies have shown that prenatally exposed to 
adverse factors could alter the global and gene- 
specific DNA methylation profiles [6]. Treatment with 
a DNA methylation donor or inhibitor can restore the 
gene expression patterns and prevent perinatal 
programed disease late in life [7-9]. In addition, 
recently we have demonstrated that the alteration of 
DNA methylation plays a key role in paternal 
hyperglycermia-induced transgenerational inheri-
tance of susceptibility to hepatic steatosis in animal 
model [10]. These studies lead to hypothesize that 
aberrant DNA methylation contributes to the GDM- 
mediated fetal programming of heart ischemia- 
sensitive phenotypes in postnatal life.  
Reactive oxygen species (ROS) are well- 
recognized as important signaling molecules 
involving in diverse biological responses [4, 11]. There 
is increasing evidence that oxidative stress plays a key 
role in the fetal programming of cardiovascular 
disorders in adulthood [12-14]. It has been shown a 
significant role of oxidative stress in the 
pathophysiology of GDM. GDM is associated with a 
heightened level of ROS, which affects both the 
mother and the fetal developing [15]. Furthermore, 
recent studies have showed a tight relation between 
ROS and DNA methylation [16]. ROS can 
differentially regulate DNA methylation patterns in 
carcinogenesis. ROS can function as catalysts of DNA 
methylation and also can induce site-specific 
hypermethylation via either the up-regulation of 
DNA methyltransferases (DNMTs) expression or the 
formation of a new DNMT containing complex [16]. 
These studies suggest that GDM-induced oxidative 
stress may directly up-regulate DNA methylation 
patterns and target specific genes in offspring hearts.  
Sirtuin 1 (Sirt1) may be one of those genes which 
are epigenetically regulated by ROS-mediated DNA 
methylation signaling mechanism. In the patho-
physiology, Sirt1 acts as a protector when suffering 
from cardiovascular disease and other disorders [12, 
17]. Of particular interest, previous studies have also 
demonstrated that activation of Sirt1 signaling mimics 
ischemic preconditioning and protects against 
myocardial I/R injury [18-20]. Of importance, 
previous studies have demonstrated that maternal 
pathologic status could induce offspring renal and 
liver disorders, which are associated with Sirt 1 
repression [21, 22]. Furthermore, increased expression 
of Sirt 1 attenuated offspring metabolic and liver 
disorders [22]. In addition, deletion of cardiac Sirt1 
gene sensitized myocardium to ischemic insults and 
impaired left ventricle functions, such as ejection 
fraction (EF) and fractional shortening (FS) [23]. These 
studies suggest that aberrant Sirt1 may contribute to 
the fetal programming of heart ischemia-sensitive 
phenotypes in postnatal life, and rescue of the 
impaired Sirt1 level may reduce the adverse effect. 
The present study was designed to reveal the 
potential epigenetic molecular mechanistic signaling 
pathway and therapeutic target for GDM-induced 
aberrant development of heart ischemia-sensitive 
phenotype in offspring. First, we established a GDM 
pregnant rat model to investigate whether GDM 
induces fetal programming of heart ischemia- 
sensitive phenotype late in life. Then we investigated 
the underlying epigenetic mechanisms and potential 
therapeutic molecular targets for reversing the heart 
ischemia-sensitive phenotype. In present study we 
examined cardiac ROS production, DNA methyl-
transferases and DNA methylation profile, Sirt 1 
protein and its down-stream autophagy-related gene 
protein levels in the offspring. Furthermore, we 
determined whether antioxidant and DNA methyla-
tion inhibitor rescued Sirt 1 and its down-stream 
proteins expression, consequently rescued the heart 
ischemia-sensitive phenotype. 
Methods 
Experimental animals 
All the procedures and protocols involved in this 
study were approved by the Institutional Animal 
Care and Use Committee of Loma Linda University 
and followed the NIH (National Institutes of Health, 
USA) Guide for the Care and Use of Laboratory 
Animals. Pregnant Sprague-Dawley rats (day 10 of 
gestation) were purchased from Charles River 
Laboratories (Portage, MI) and housed individually in 
cages which located in air-conditioned rooms (room 
temperature 22 °C, relative humidity 60%; lights on 
from 8:00 a.m. to 8:00 p.m.). Pellet food and tap water 
were available ad libitum. On day 12 of gestation, rats 
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were divided into two groups randomly: 1) saline 
control (n=6) and 2) streptozotocin (STZ) (n=8) group. 
The pregnant rats were received a subcutaneous 
injection of saline or STZ (50 mg/kg) (Sigma, USA) as 
described in previous studies [24-26]. STZ has been 
widely used as a tool for inducing experimental 
diabetes because of its relatively specific pancreatic β 
cell cytotoxic effect [18, 24, 26]. The experimental 
rationale for use of STZ to develop an animal model of 
late gestational diabetes is that STZ can induce 
maternal hyperglycemia without directly significantly 
affecting the fetuses [26, 27]. Because STZ is imported 
by β cells via the GLUT2 transporter followed by 
induction of β cell necrosis, whereas, fetal β cell has 
lower levels of GLUT2 compared to adults [27]. The 
blood glucose levels in the dams and offspring were 
measured via tail-nicking using the Germaine Labor-
atories AimStrip Plus Blood Glucose Testing System 
(Fisher Scientific, Pittsburgh PA. Cat# 23-111-275) 
following manufacturer’s instructions. A total of 64 
pups from saline controls and 93 pups from STZ- 
treated dams were born. There was no difference of 
the litter sizes between the controls (10.7 ± 2.2 pups/ 
litter) and STZ-treated dams (11.6 ± 0.4 pups/litter).  
After weaning (3 weeks after birth), the offspring 
from both groups were divided randomly into four 
groups: 1) control – ROS inhibitor, N-acetyl-cysteine 
(NAC); 2) control + NAC; 3) STZ – NAC; and 4) STZ 
+NAC. Antioxidant NAC (500 mg/kg/day) was 
placed in the drinking water which was concurrently 
started at weaning day (3-week-old) until 6-week-old. 
The rationale for using this dosage of NAC is that it 
can inhibit ROS production without significant side 
effect in rats as previously described [14, 28, 29]. After 
treatment, the male and female rat offspring were 
used for following cardiac functional and molecular 
biologic studies. 
Heart ischemic model and measurement of 
myocardial infarct size  
At the age of 6 weeks-old, the offspring rats were 
subjected to induce heart ischemia procedure in vivo 
as described previously [30]. Briefly, rats were 
anesthetized with isoflurane (5% for induction, 3% for 
maintenance) (Vet ONE, USA) by inhalation and 
placed on the RoVent Jr. Small Animal Ventilator 
(Kent Scientific). The rat body weight was used to 
adjust respiratory parameters on the mechanical 
ventilator. The ischemia was induced by an occlusion 
on left anterior descending artery (LAD) with a 6-0 
PROLENE® suture (Ethicon, USA). After surgery, 
offspring were recuperated for 20 min in a single cage 
and then returned to their house cages. The rationale 
for use of 6-week old LAD ligation model in this 
study is to identify the early biomarkers of heart 
ischemic dysfunction and to provide an early time 
point to assess young offspring hearts’ susceptibility 
to ischemic injury. 
For measurement of cardiac infarct size, one set 
of rats from each group were sacrificed after 24 hours 
of ischemia. The whole hearts were collected and cut 
into five slices on the ice. Then, heart slices were 
incubated in 2,3,5-triphenyltetrazolium chloride 
(TTC) (Sigma-Aldrich, USA) for 10 minutes at room 
temperature and immersed in formalin (Thermo 
Scientific, USA) over night. Slices were photographed 
and the areas of myocardial infraction and LV were 
analyzed by Image J (National Institutes of Health, 
USA), which is a java-based image processing 
program. The size of myocardial infarct was 
expressed as the ratio of myocardial infarct size to 
whole LV area, as previously described [9, 31]. 
Measurement of cardiac function 
 Another set of rats from each group were used 
for cardiac functional studies. The cardiac function 
was assessed by echocardiography (GE Healthcare, 
USA) before and 7 days after heart ischemia as 
previously described [32]. Briefly, offspring were 
anesthetized with inhalation of 3.5% isoflurane and 
placed on a pre-warmed (37 ℃) work surface. Then 
the rats were placed in the left lateral decubitus 
position. M-mode recording of the LV was obtained at 
the level of the mitral valve in the parasternal view 
using two-dimensional (2D) echocardiographic 
guidance in both short and long axis views. Cardiac 
function and heart dimensions were evaluated by 2D 
echocardiography on the anesthetized (2% isoflurane) 
rat. M-mode tracing was used to measure functional 
parameters such as LV end-diastolic dimension 
(LVEDD), LV end-systolic dimension (LVESD), LV 
end-diastolic volume (LVEDV) and LV end-systolic 
volume (LVESV) were calculated using the above 
primary measurements and accompanying software. 
The percentage of LV ejection fraction (EF) was 
calculated as (LVEDV-LVESV)/LVEDV x 100% and 
the percentage of LV fractional shortening (FS) was 
calculated as (LVEDD-LVESD)/LVEDD x 100%. 
Echocardiography data were recorded and analyzed 
blindly to the different treatments. 
Western blot analysis 
The total protein samples were isolated from left 
ventricles (LVs) tissues from the offspring and were 
homogenized in lysis buffer containing 150 mM NaCl 
(Bio-Rad, USA), 50 mM Tris·HCl (Bio-Rad, USA), 10 
mM EDTA (Bio-Rad, USA), 0.1% Tween (Fisher, 
USA), 0.1% β-mercaptoethanol (Bio-Rad, USA), 0.1 
mM phenylmethylsulfonyl fluoride (Bio-Rad, USA), 5 
ug/mL leupeptin (Bio-Rad, USA), and 5 ug/mL 
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aprotinin (Bio-Rad, USA), pH 7.4. Then, the 
homogenates were centrifuged at 4°C for 15 min at 
12,000 g and the supernatants were collected. Samples 
with equal amount of total protein were loaded in the 
8% or 10% polyacrylamide gel with 0.1% SDS 
(Bio-Rad, USA) and were separated by 
electrophoresis at 100 V for 80 min. Proteins were then 
transferred onto nitrocellulose membranes (Bio-rad, 
USA) and blocked for 3 h at room temperature. The 
membranes were incubated at 4 ℃ with primary 
antibodies against Sirtuin 1 (SIRT1) (Cell Signaling 
Technology, USA), DNA methyltransferase (DNMT) 
1, 3a, 3b (Cell Signaling Technology, USA), NADPH 
oxidase (NOX) 1, 2, 4 (Boster Biological Technology, 
USA), p-Akt (Cell Signaling Technology, USA), Akt 
(Cell Signaling Technology, USA), Beclin1 (Cell 
Signaling Technology, USA), Atg5 (Cell Signaling 
Technology, USA), LC3B (Cell Signaling Technology, 
USA) and GAPDH (MilliporeSigma, USA), 
respectively. After washing and incubating with 
secondary antibodies, protein bands were visualized 
with enhanced chemiluminescence reagents and 
captured by photographic films (MidSci, USA). The 
films were analyzed with the document imaging 
scanner (HP, USA) with gray mode. Band intensities 
were normalized to GAPDH. 
Measurement of ROS level 
Tissues from LVs were homogenized on the ice 
at 30 mg/mL in Phosphate Buffered Saline (PBS) and 
centrifuged at 10000 for 5 min at 4 ℃. The total ROS 
levels in the LV tissue samples were measured with 
the OxiselectTM in vitro ROS/RNS assay kit (Cell 
Biolabs, Inc. San Diego, CA), following the 
manufacturer’s instruction. Briefly, 50 µL of the 
samples or standard were added to a 96-well plate 
and mixed with 50 µL of catalyst and 100 µL of 
2’,7’-dichlorodihydrofluorescein diacetate (DCF). 
After incubation at room temperature for 30 min, the 
fluorescence (Ex480 nm/Em530 nm) was measured 
using a Synergy HT Multi-Mode Microplate Reader 
(Bio-Tek Instruments, Inc., Winooski, VT, USA). 
5-mC DNA ELISA 
Total DNA were isolated from LVs with 
A260/280 >1.6. The global DNA methylation levels in 
each sample of LV were determined by the detection 
of global 5-methylcytosine (5-mC) in genomic DNA 
that was isolated from the LV tissues using a 5-mC 
DNA ELISA kit (Zymo Research, USA) following the 
manufacturer’s instructions. Briefly, 100 ng of each 
DNA sample and Negative/Positive Controls were 
mixed respectively with 5-mC coating Buffer, 
denatured at 98 ℃ for 5 min and cooled on ice for 10 
min. After incubation at 37 ℃ for 1 h, each well of the 
96 well plate was washed 3 times with 5-mC ELISA 
Buffer and incubated again at 37 ℃ for 30 min. 
Antibody mix consisting of Anti-5-Methylcytosine 
and Secondary Antibody in 5-mC ELISA Buffer were 
added into each well and incubated at 37 ℃ for 1 h. 
Then wells were washed with 5-mC ELISA buffer 3 
times and a HRP developer was added to each well 
and incubated at room temperature for 30 min. The 
absorbance at 405 nm was measured using an ELISA 
plate reader. The 5-mC percentage for DNA samples 
was calculated using the logarithmic second-order 
regression equation at the standard curve that was 
constructed with negative and positive controls in the 
same experiment. 
Treatment with DNA methylation inhibitor, 
5-aza-2’-deoxycytodine (5-Aza) in ex vivo 
cultured fetal heart.  
Fetal rat hearts were isolated on the gestational 
day 19 and were cultured in M199 media (Hyclone) 
supplemented with 10% FBS and 1% penicillin/ 
streptomycin at 37 °C in 95% air/ 5% CO2 as 
previously described [33, 34]. After 24 h incubation in 
M199 culture media. The DNA methylation inhibitor, 
5-aza-2’-deoxycytodine (Sigma), was added to the 
media at a final concentration of 10 μM. The control 
group was given the same volume of vehicle. Media 
was changed at 24 h intervals during the treatment. 
After 48 h of treatment, fetal hearts were harvested for 
further western blotting analysis. 
Statistical analysis 
All data are expressed as the mean ± SEM 
obtained from the number (n) of experimental 
animals given. Difference between the groups was 
compared by Student’s t-test or analysis of variance 
(ANOVA) using the Graph-Pad Prism software 
(GraphPad Software Version 5, San Diego, CA, USA), 
where appropriate. For all comparisons, P-values less 
than 0.05 indicated statistical significance. 
Results 
Effect of GDM on body weight and blood 
glucose in pregnant rats and their offspring 
To develop a GDM model, we treated the 
pregnant rats on gestational day 12 with STZ as 
previously described [24, 25, 35, 36]. As shown in 
Figure 1, treatment with STZ showed a 
time-dependent increase in blood glucose level and 
constantly remained higher blood glucose level 
throughout period of pregnancy (Figure 1A), which 
was associated a decrease in maternal body weight 
gain (Figure 1B). As shown in figure 1C and Table 1, 
prenatal STZ exposure had no effect on blood glucose 
in both male and female offspring. However, prenatal 
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STZ exposure significantly decreased the body weight 
(Figure 1D) and heart weight (Figure 1E) in both male 
and female offspring, while the heart to body weight 
ratio did not have difference between STZ group and 
control group (Figure 1F). 
Effect of GDM on baseline heart function and 
ischemia-induced heart dysfunction in 
offspring 
As shown in the Table 2, there were no 
significant differences of the baseline heart function 
measured by echocardiography between the GDM 
exposed group and the control group of both male 
and female offspring at the age of 6-week-old. 
However, 24 h ligation ischemia produced higher 
cardiac infarction size in the GDM exposed group 
than in the control group for both male and female 
offspring (Figure 2). In addition, as shown in the Table 
2 and figure 3, GDM exposure significantly affected 
heart function 7 days after ischemia and attenuated 
the post-ischemic recovery of EF (Figure 3B), FS 
(Figure 3C) and SV (Figure 3D) only in male but not in 
female offspring as compared with control group.  
GDM induced oxidative stress in offspring 
hearts 
Because there was no difference of cardiac 
function between STZ and control group after heart 
ischemia in the female offspring (Figures 3 and Table 
2), all of the following molecular biologic studies were 
only performed in male offspring. As shown in Figure 
4A, the levels of ROS in LV tissues were significantly 
increased in STZ-treated group as compared with the 
control group in male offspring. In addition, the 
protein levels of NOX1 and NOX2 but not NOX4 were 
also up-regulated in LV tissues of male offspring in 
STZ-treated group as compared with the control 
group (Figure 4B). However, chronic treatment with 
the antioxidant, NAC reversed GDM-mediated ROS 
production in the male offspring (Figure 4C). Further-
more, treatment with NAC rescued GDM-mediated 
ischemia-induced infarction (data not shown) and 
cardiac dysfunction (Table 3) in the male offspring. 
 
Table 1.   Effect of prenatal STZ on blood glucose, HW, BW and 
HW/BW in offspring 7 days after heart ischemia in the absence and 
presence of NAC 
 
Note: STZ, streptozotocin; CTRL, control; HW, heart weight; BW, body weight; 
NAC, N-acetyl-cysteine; -NAC, in the absence of NAC; +NAC, in the presence of 
NAC; M, male; F, female. *P < 0.05 
 
 
Figure 1. Effect of GDM on body weight and blood glucose in pregnant rats and their offspring. Pregnant rats were administered with either saline or 
STZ with 50 mg/kg on 12th day of gestation. A) Showing the daily blood glucose values in pregnant dams with diabetes induced by injection of STZ (●) on day 12 of 
gestation and sham control (○). B) Showing the maternal body weight gain values after STZ treatment (●) and sham control (○). C) Showing the blood glucose levels 
in both male and female offspring of STZ-treated (■) and control (□) groups at 6 weeks-old. D) Showing the body weights in both male and female offspring of 
STZ-treated (■) and control (□) groups at 6 weeks-old. E) Showing the heart weights in both male and female offspring of STZ-treated (■) and control (□) groups at 
6 weeks-old. F) Showing the heart weight (HW)/body weight (BW) ratio in both male and female offspring of STZ-treated (■) and control (□) groups at 6 weeks-old. 
Values are means ± SE, *p < 0.05 compared to control. 
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Table 2.   Effect of prenatal STZ on LV parameters in offspring before heart ischemia and 7 days after heart ischemia 
 
Note: CTRL, control; STZ, streptozotocin; IVSd/ IVSs, interventricular septal end diastolic/systolic dimension; LVEDD/ LVESD, left ventricular end-diastolic/ systolic 
dimension; LVPWd/ LVPWs, left ventricular posterior wall thickness at end diastole/systole; EF, ejection fraction; FS, fractional shortening; SV, stroke volume; LV EDV/ LV 
ESV, left ventricular end-diastolic/ systolic volume; HR, heart rate; M, male; F: female. *P < 0.05 vs. control. 
 
Table 3.   Effect of NAC treatment of prenatal STZ-induced changes of LV parameters in male offspring before heart ischemia and 7 days 
after heart ischemia 
 
Note: NAC, N-acetyl-cysteine; CTRL, control; STZ, streptozotocin; IVSd/ IVSs, interventricular septal end diastolic/systolic dimension; LVEDD/ LVESD, left ventricular 
end-diastolic/ systolic dimension; LVPWd/ LVPWs, left ventricular posterior wall thickness at end diastole/systole; EF, ejection fraction; FS, fractional shortening; SV, 
stroke volume; LV EDV/ LV ESV, left ventricular end-diastolic/ systolic volume; HR, heart rate. 
 
Effect of GDM on Sirt1 and autophagy-related 
protein abundances in male offspring hearts 
As shown in Figure 5A-B, GDM exposure 
significantly decreased the offspring cardiac protein 
expressions of Sirt1 and its downstream target 
p-Akt/Akt as compared with control group in the 
absence of NAC treatment. However, there were no 
significant differences of the protein expressions of 
Sirt1 and p-Akt/Akt ratio between the GDM exposed 
and control offspring after the treatment of NAC 
(Figure 5C and 5D). Furthermore, prenatal STZ 
exposure promoted autophagy activity in offspring 
heart tissues. As shown in Figure 6, there were 
significant increases in autophagy-related protein 
LC3B II/I ratio (Figure 6A) and Atg 5 (Figure 6B) but 
not Beclin 1 (Figure 6C) levels of cardiac tissues in STZ 
exposed offspring as compared to the controls. 
However, NAC treatment reversed the effects of STZ 
on LC3B II/I ratio (Figure 6C), Atg 5 (Figure 6D) and 
Beclin 1 (Figure 6E) protein expression levels in the 
offspring heart tissues. 
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Figure 2. Effect of GDM exposure on ischemia-induced myocardial 
infarction in offspring. Offspring from each group were subjected heart 
ischemia as indicated in the Methods Section. 24 hours after heart ischemia, the 
hearts were isolated and their infarct sizes were determined with 2% TTC 
staining (A). The bar graph (B) showing percent of left ventricle infarct size 
(infarct area/risk area x100%) in each offspring group. Data are means ± SEM of 
animals from each group (n=6-5 in male offspring, n=5-7 in female offspring) 
were analyzed by 2-way ANOVA. *P < 0.05 versus. 
 
 
Figure 3. Effect of GDM on heart function in offspring. The 
echocardiographic data of both the control and STZ exposed groups were 
examined at 7 days after heart ischemia, as described under Methods Section. 
(A) A representative echocardiography shows the measurement of LVSd, 
LVEDd, LVPWd, LVSs, and LVPWs. (B) Percent of ejection fraction (EF), (C) 
Percent of fractional shortening (FS), and (D) Stroke volume (SV) in both male 
and female offspring of STZ-treated (■) and control (□) groups at 7th day after 
heart ischemia. Data are means ± SEM of animals from each group (n=9-12 in 
male offspring, n=14-7 in female offspring) were analyzed by 2-way ANOVA. *P 
< 0.05 versus control. 
Effect of GDM on DNA methylation and the 
role of DNA methylation in regulation of Sirt 1 
gene expression 
As shown in Figure 7A, the global DNA methyl-
ation levels in the LV tissues were significantly higher 
in the STZ-treated offspring than in the control group. 
The changes of DNA methylation were associated 
with a selective increase in DNMT3A but not DNMT1 
and DNMT3B protein expression (Figure 7B). As 
shown in Figure 7C and 7D, treatment with NAC 
reversed the effects of STZ on global DNA methyla-
tion and DNMT3A expression in the offspring heart 
tissues. 
To see whether DNA methylation plays a key 
role in regulation of Sirt 1 gene, we treated the fetal 
hearts with DNA methylation inhibitor, 5-Aza ex 
vivo. As shown in Figure 8, treatment with 5-Aza 
significantly decreased cardiac DNMT3A protein 
expression (Figure 8A), but increased the expression 
of Sirt 1 (Figure 8B) in the fetal hearts. 
Discussion 
GDM is a worldwide disease which affects up to 
16% of pregnant women globally, and it has adverse 
effects on both mother and child [37, 38]. Exposure to 
diabetes in utero is one of the most important risk 
factors for development of cardiovascular dysfunction 
[39-41]. Most of the previous studies have been 
mainly focusing on the effects of pre-gestational 
diabetes. In present study, we have developed a rat 
model of diabetes with maternal hyperglycemia 
limited to the last third of pregnancy (gestational day 
16 ~ 21), which is similar to that occurring with 
gestational diabetes in clinic. Our present data 
indicated that late maternal gestational hypergly-
cemia significantly decreased the body and heart 
weights of both male and female offspring as 
compared with the control group. However, the 
effects of maternal diabetes on offspring body size are 
not consistent. Pre-gestational maternal diabetes and 
later gestation maternal diabetes have produced 
either large [26, 42] or small [26, 43] offspring. The 
reasons for this discrepancy are unclear. However, 
previous studies suggest that the heavier offspring 
tended to come from mothers with mild 
hyperglycemia, whereas the underweight offspring 
were most likely from mothers with more severe 
hyperglycemia [26].  
In human and animal studies, in utero exposure 
to diabetes is associated with aberrant development of 
fetal heart and fetal heart dysfunction [39-41, 44]. The 
present study further demonstrated that exposure to a 
hyperglycemia in utero environment leads to 
impairment of cardiac function that persist into late 
life. Specifically, although the bassline cardiac 
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functions measured by echocardiography were no 
difference between the control and GDM-exposed 
offspring at 6 weeks of age, we found that ischemic 
insult-induced cardiac infarction sizes were 
significantly increased in GDM-exposed offspring as 
compared to controls. In addition, we also found that 
compared to controls, GDM-exposed offspring had 
diminished cardiac function in response to ischemic 
challenge. These findings suggest that GDM exposure 
may not impair offspring heart function at resting 
condition but enhance the heart susceptibility to 
ischemic insult and development of heart ischemia- 
sensitive phenotype in young offspring. Similar 
findings have been reported in different animal 
models where in utero exposure to adverse 
environmental stimuli have had no effect on cardiac 
function at resting condition while enhances the 
cardiac ischemic infarction and dysfunction after 
ischemia stimulation [14, 32]. The present finding that 
GDM caused a gender-dependent attenuation of 
cardiac functional recovery after 7 days of ischemic 
stimulation in male but not female offspring, suggests 
a gender difference in response to GDM exposure. 
The gender differences found in this study are not 
surprised and have been reported in different models 
of fetal programming of cardiovascular disease [31, 
45, 46]. The majority of these studies have shown that 
male offspring are more affected by the adverse in 
utero environment than female offspring. Further-
more, in present study, we found that GDM exposure 
enhanced ischemia-induce cardiac infarction in both 
male and female offspring after 24 h of ischemic 
stimulation. However, the enhanced cardiac 
dysfunction was only observed in male but not female 
offspring after 7 days of ischemic stimulation. These 
findings suggest that female offspring heart has much 
higher compensated mechanism than male offspring 
heart in response to ischemic insult. The underlying 
mechanisms by which biological sex contributes to 
these developmental programed cardiovascular 
dysfunctions remains unclear at present; nevertheless, 
it has been proposed that some of the intriguing 
mechanistic molecules and proteins such as sex 
hormones and recently reported sexual dimorphism 
in the transcriptome of a variety of tissues many play 
a key role in the gender difference in the development 
of cardiovascular disease late in life. Therefore, in our 
future studies, we will consider the underlying 
mechanisms of gender differences as further 
investigation into the developmental origins of 
cardiovascular dysfunction. 
Although the underlying mechanisms that may 
lead to enhanced susceptibility to ischemic insult in 
the GDM-exposed male offspring are unknown, 
exaggerated ROS or enhanced sensitivity to oxidative 
stress may be one of the key mechanisms contributing 
to the heart dysfunction. Recent studies have 
demonstrated that an adverse uterine environment, 
including maternal diabetes and obesity, alters 
oxidative pathways and induces oxidative stress in 
offspring [47, 48]. Consistent with the previous 
studies, the present study also showed increases in 
cardiac ROS productions and ROS-associated 
NADPH oxidases (NOX1 and NOX2) in the GDM- 
exposed offspring. In addition, previous studies have 
suggested that ROS is a hallmark of cardiovascular 
disease and participates the pathophysiological 
change in cardiac ischemia/reperfusion injury [49, 
50]. Our current data that pretreatment of the 
offspring with an antioxidant N-acetylcysteine (NAC) 
blocked the enhanced ROS and improved heart 
functional recovery following the ischemic insult, 
suggests that the enhanced ROS is one of the 
 
 
Figure 4. Effect of GDM on the ROS level in offspring. Heart tissues 
were isolated from male offspring. (A) ROS levels in the left ventricle (LV) 
tissues isolated from both control (□) and STZ-treated (■) groups were 
measured using in vitro ROS/RNS assay kit. (B) NOX1, 2, and 4 protein 
abundances in the LV tissues isolated from both control (□) and STZ-treated (■) 
groups were determined by Western blot analysis. Their protein densities were 
normalized to internal control (GAPDH). (C) After NAC pretreatment, ROS 
levels in the LV tissues isolated from both control (□) and STZ-treated (■) 
groups were measured using in vitro ROS/RNS assay kit. Data are means ± SEM 
(n=4 animals/group). *P < 0.05 vs. control, as determined by Student’s t-test. 
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important molecular mechanisms underlying GDM- 
induced fetal programming of cardiac dysfunction 
late in life. Furthermore, the present study also 
provides novel therapeutic approaches for improve-
ment of the programmed cardiac function with 
supplemental antioxidant.  
 A decrease in Sirt1 protein expression in male 
offspring heart tissues was observed in GDM-exposed 
group as compared to the controls. This finding 
suggests that Sirt1 may be one of the molecular 
mechanisms in maternal GDM-induced aberrant 
development of heart ischemia-sensitive phenotype in 
offspring. Indeed, previous studies have demonstra-
ted that Sirt 1 expression is reduced in diabetic heart 
and overexpression of Sirt 1 by adenoviral vectors 
encoding Sirt 1 could reduce diabetes-exacerbated 
myocardial infarct size and improves cardiac function 
in diabetic rats [18]. Sirt1 functions as an acetylation 
regulator to maintain cardiac mitochondrial integrity 
and normal postnatal myocardium development [51]. 
Moreover, Sirt1-mediated deacetylation of lysines and 
PDK1 locates in the PH domain of Akt, resulting in 
direct upregulation of Akt signaling [52, 53]. Similar 
to the reduced Sirt 1 expression, our present study has 
shown that Akt phosphorylation levels were 
significantly attenuated in GDM-exposed offspring 
hearts as compared to the controls. Regulation of Akt 
signaling by Sirt 1 has significant implication in the 
development of cardiac disease via control of a variety 
of cellular processes, such as apoptosis and auto-
phagy [54]. Akt is one of the key signaling pathways 
in negative regulation of autophagy in myocardial 
ischemic injury [55]. 
Autophagy is well documented to be involved in 
diverse pathological processes [56]. In present study, 
we examined the status of autophagy-related 
biomarkers including Atg5, Beclin1 and LC3B II/I in 
the offspring heart tissues. Our data indicated that 
Atg5 and LC3B-II/I was overexpressed in GDM- 
exposed hearts as compared to the controls. These 
findings suggest that the exaggerated autophagy 
signaling may be one of the molecular mechanisms 
underlying GDM-mediated development of heart 
ischemia-sensitive phenotype in rat offspring. 
Furthermore, our present finding that pretreatment of 
the offspring with antioxidant NAC reversed GDN- 
mediated changes of Sirt 1, Akt phosphorylation and 
autophagy-related protein expressions in the heart 
tissues, suggests that GDM-induced ROS is 
the up-stream regulator.  
DNA methylation is one of the key 
epigenetic mechanisms in modification of 
gene expression patterns and occurs at CpG 
sites in promoter region, leading to a 
long-term shutdown of the associated gene 
[4, 5]. Previous studies have shown that 
GDM exposure could alter global and 
gene-specific DNA methylation profile in 
offspring [57, 58]. Similarly, in present study, 
our data showed that global DNA methyla-
tion level was increased in GDM-exposed 
offspring as compared to the controls, which 
was associated with a selective increase in 
Dnmt 3A protein expression in the offspring 
heart tissues. Furthermore, our present data 
showed that pre-treatment of fetal hearts ex 
vivo with DNA methylation inhibitor 5-Aza 
significantly attenuated Dnmt 3A protein 
expression and increased Sirt 1 protein 
expression. These findings suggest that 
GDM-mediated Sirt 1 repression is epigeneti-
cally regulated by DNA hypermethylation 
mechanism in the offspring heart. However, 
it is unknown at present whether this is a 
direct or indirect regulation. In our future 
study we will investigate the effect of DNA 
methylation inhibitor on Sirt 1 gene promoter 
activity to confirm whether this is a direct 
regulation. In addition, the present findings 
 
 
Figure 5. Effect of GDM on the protein expression of Sirt1 and p-Akt/Akt in male 
offspring. The hearts were isolated from both control (□) and STZ-treated (■) groups of 
male offspring. The protein abundance in the LV tissue was determined by Western blot 
analysis. The Sirt1 protein density (A) and P-Akt/Akt protein density (B) in the LV tissues of 
the groups which had not treated with NAC. The Sirt1 protein density (C) and P-Akt/Akt 
protein density (D) in the LV tissues of the groups which had treated with NAC. Data are 
means ± SEM (n=4 animals/group). *P < 0.05 vs. control, as determined by Student’s t-test. 
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of enhanced global cardiac DNA methylation 
suggests that altered methylation does not only 
regulate Sirt 1 expression but also could regulate other 
target genes expressions.  
Enhanced levels of both ROS and DNA 
methylation are one of the most common characteris-
tics in human programmed disease. However, the 
relation between these two is not well understood. 
Previous studies have reported that ROS-induced 
oxidative stress can function as catalysts of DNA 
methylation and induce site-specific hypermethyla-
tion via either the up-regulation of Dnmts expression 
or the production of a new Dnmt containing complex 
[16, 54]. In present study, our findings that 
pre-treatment of offspring with ROS inhibitor NAC 
reversed GDM-mediated Dnmt 3A over-expression 
and DNA hypermethylation in cardiac tissues, 
suggest a cause-consequence relationship between 
GDM-induced ROS and DNA methylation. The 
ROS-induced DNA methylation pattern alteration 
may play an important role in epigenetic 
down-regulation of Sirt 1 gene in the GDM –exposed 
offspring hearts.  
 Study limitations: 1) In our present study, we 
found that GDM exposure caused offspring growth 
restriction. However, the molecular mechanisms 
underlying GDM-mediated offspring growth 
restriction are not fully understood. Therefore, in our 
future studies, we need to investigate whether GDM 
exposure epigenetically alters development and 
growth-associated hormones levels and genes 
expressions. 2) In present study we investigated the 
effect of fetal GDM exposure on the postnatal 
cardiovascular function. Although the offspring from 
each dam are randomly divided into each 
experimental group, one of the limitations for this 
study is that we used the number of offspring as 
experimental number (n). 3) Our present results 
indicated that GDM exposure had no effect on cardiac 
function in female offspring, however, this does not 
mean that the heart ischemia-sensitive target 
proteins are not altered by GDM exposure in 
females, which opens a wide door for our 
future studies.  
In conclusion, our present study provides 
a novel evidence that GDM exposure is one of 
the important risk factors in the aberrant 
development of heart ischemia-sensitive 
phenotype in offspring in gender-dependent 
manner. Specifically, our data indicated that 
GDM exposure caused an increase in ROS 
production and induced oxidative stress in 
offspring heart tissues. The enhanced ROS 
selectively activated and increased DNA 
methyltransferase (Dnmt 3A) expression, 
leading to DNA hypermethylation. GDM 
exposure attenuated cardiac Sirt1 protein 
expression and decreased Akt phosphoryla-
tion, which was regulated by DNA methyla-
tion. The GDM-mediated down-regulation of 
Sirt 1/Akt signaling promoted the progress of 
autophagy, resulting in aberrant development 
of heart ischemia- sensitive phenotype in 
offspring. Furthermore, antioxidant treatment 
could reverse the GDM- mediated DNA 
hypermethylation, Sirt 1 repression, and auto-
phagy signaling, consequently rescue GDM- 
induced heart ischemia-sensitive phenotype. 
With improved understanding of the 
epigenetic molecular mechanisms underlying 
gestational diabetes milieu-induced fetal 
programming of cardiovascular dysfunction, 
our findings may provide novel therapeutic 
strategies to prevent or rescue the develop-
ment of cardiovascular disease later in life.  
 
 
Figure 6. Effect of GDM on autophagy-related protein expression in male 
offspring. The hearts were isolated from both control (□) and STZ-treated (■) groups of 
male offspring. The protein abundance in the LV tissue was determined by Western blot 
analysis. The LC3B-I/II protein density (A), Atg5 protein density (B), and Beclin 1 protein 
density (C) in the LV tissues of the groups which had not treated with NAC. The LC3B-I/II 
protein density (D), Atg5 protein density (E), and Beclin 1 protein density (F) in the LV 
tissues of the groups which had treated with NAC. Data are means ± SEM (n=4 
animals/group). *P < 0.05 vs. control, as determined by Student’s t-test. 
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Figure 7. Effect of GDM on the global DNA methylation and DNA 
methyltransferase (DNMT) protein expression in male offspring. The 
hearts were isolated from both control (□) and STZ-treated (■) groups of male 
offspring. Global DNA methylation levels in LV tissues of male offspring, which 
were without (A) or with (C) NAC treatment, were measured using in 5-mC 
DNA ELISA kit. The protein abundances of DNMTs in the left ventricle tissues 
of male offspring, which were without (B) or with (D) NAC treatment, were 
determined by Western blot analysis. Data are means ± SEM (n=4 
animals/group). *P < 0.05 vs. control, as determined by Student’s t-test. 
 
Figure 8. Effect of DNA methylation inhibitor on Sirt 1 protein 
expression in fetal hearts ex vivo. Fetal rat hearts were isolated from 
gestational day 19 and were cultured in an incubator. After 48 hours of 
treatment with DNA methylation inhibitor, 5-aza-2’-deoxycytodine (5-Aza, 10 
μM) (■) or control vehicle (□). The protein levels of DNMT3a (A) and Sirt 1 (B) 
in the fetal hearts were determined by Western blot analysis. Data are means ± 
SEM (n=6 hearts/group). *P < 0.05 vs. control, as determined by Student’s t-test.  
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